Earlier this week, the CDC Advisory Committee on Immunization Practices approved the distribution of the Pfizer-BioNTech COVID-19 vaccine to children 5 through 11 years old. This vaccine had already received an emergency use authorization (EUA) for that same age group from the FDA. As a result...